Richard A. Heyman insider trades: Oric Pharmaceuticals (ORIC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
and 3 more companies
Open-market buys and sales
38 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ORIC | ↓ Sell | 3,500 | $12.91 | $45K | Direct | Oct 2, 2026 (1d) |
| Oct 1, 2026 | ORIC | ↓ Sell | 3,200 | $12.91 | $41K | Indirect | Oct 2, 2026 (1d) |
| Jul 6, 2026 | ORIC | ↓ Sell | 300 | $12.00 | $4K | Indirect | Jul 8, 2026 (2d) |
| Feb 17, 2026 | ELVN | ↓ Sell | 1,230 | $26.18 | $32K | Indirect | Feb 19, 2026 (2d) |
| Jan 20, 2026 | ELVN | ↓ Sell | 1,230 | $26.75 | $33K | Indirect | Jan 22, 2026 (2d) |
| Jan 16, 2026 | ORIC | ↓ Sell | 3,500 | $12.00 | $42K | Direct | Jan 20, 2026 (4d) |
| Jan 16, 2026 | ORIC | ↓ Sell | 3,200 | $12.00 | $38K | Indirect | Jan 20, 2026 (4d) |
| Jan 9, 2026 | ELVN | ↓ Sell | 13,920 | $25.02 | $348K | Indirect | Jan 12, 2026 (3d) |
| Oct 18, 2024 | ELVN | ↓ Sell | 817 | $30.00 | $25K | Direct | Oct 22, 2024 (4d) |
| Oct 18, 2024 | ELVN | ↓ Sell | 753 | $30.00 | $23K | Indirect | Oct 22, 2024 (4d) |
| Oct 15, 2024 | ELVN | ↓ Sell | 1,270 | $27.67 | $35K | Direct | Oct 17, 2024 (2d) |
| Oct 4, 2024 | ELVN | ↓ Sell | 2,825 | $27.51 | $78K | Direct | Oct 8, 2024 (4d) |
| Oct 1, 2024 | ELVN | ↓ Sell | 518 | $27.54 | $14K | Direct | Oct 3, 2024 (2d) |
| Sep 16, 2024 | ELVN | ↓ Sell | 1,270 | $22.41 | $28K | Direct | Sep 18, 2024 (2d) |
| Aug 15, 2024 | ELVN | ↓ Sell | 1,270 | $23.25 | $30K | Direct | Aug 19, 2024 (4d) |
| Jul 31, 2024 | ELVN | ↓ Sell | 1,702 | $27.51 | $47K | Direct | Aug 2, 2024 (2d) |
| Jul 31, 2024 | ELVN | ↓ Sell | 649 | $27.50 | $18K | Indirect | Aug 2, 2024 (2d) |
| Jul 15, 2024 | ELVN | ↓ Sell | 1,270 | $24.80 | $31K | Direct | Jul 17, 2024 (2d) |
| Jun 17, 2024 | ELVN | ↓ Sell | 1,270 | $21.48 | $27K | Direct | Jun 20, 2024 (3d) |
| May 16, 2024 | ELVN | ↓ Sell | 1,270 | $23.74 | $30K | Direct | May 20, 2024 (4d) |
| Apr 15, 2024 | ELVN | ↓ Sell | 6,315 | $24.02 | $152K | Direct | Apr 15, 2024 (0d) |
| Apr 11, 2024 | ELVN | ↓ Sell | 649 | $25.00 | $16K | Indirect | Apr 15, 2024 (4d) |
| Mar 19, 2024 | ELVN | ↓ Sell | 1,270 | $14.50 | $18K | Direct | Mar 21, 2024 (2d) |
| Feb 15, 2024 | ELVN | ↓ Sell | 1,270 | $17.42 | $22K | Direct | Feb 20, 2024 (5d) |
| Jan 30, 2024 | ELVN | ↓ Sell | 1,270 | $16.41 | $21K | Direct | Feb 1, 2024 (2d) |
| Dec 22, 2023 | ELVN | ↓ Sell | 175 | $13.00 | $2K | Direct | Dec 26, 2023 (4d) |
| Dec 22, 2023 | ELVN | ↓ Sell | 41 | $13.00 | $533 | Indirect | Dec 26, 2023 (4d) |
| Dec 20, 2023 | ELVN | ↓ Sell | 2,365 | $13.02 | $31K | Direct | Dec 21, 2023 (1d) |
| Dec 20, 2023 | ELVN | ↓ Sell | 1,915 | $13.02 | $25K | Indirect | Dec 21, 2023 (1d) |
| Sep 15, 2021 | ORIC | ↓ Sell | 1,388 | $25.04 | $35K | Indirect | Sep 16, 2021 (1d) |
| Sep 13, 2021 | ORIC | ↓ Sell | 1,080 | $25.05 | $27K | Indirect | Sep 14, 2021 (1d) |
| Sep 7, 2021 | ORIC | ↓ Sell | 1,086 | $25.11 | $27K | Indirect | Sep 9, 2021 (2d) |
| Jun 1, 2021 | PMVP | ↓ Sell | 3,898 | $32.55 | $127K | Indirect | Jun 2, 2021 (1d) |
| May 24, 2021 | ORIC | ↓ Sell | 1,400 | $25.15 | $35K | Indirect | May 24, 2021 (0d) |
| May 18, 2021 | ORIC | ↓ Sell | 5,874 | $25.29 | $149K | Indirect | May 18, 2021 (0d) |
| May 11, 2021 | ORIC | ↓ Sell | 100 | $25.11 | $3K | Indirect | May 13, 2021 (2d) |
| Apr 30, 2021 | ORIC | ↓ Sell | 200 | $25.17 | $5K | Indirect | Apr 30, 2021 (0d) |
| Apr 1, 2021 | ORIC | ↓ Sell | 100 | $25.00 | $3K | Indirect | Apr 5, 2021 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ORIC insiders
Open-market trades in the last 12 months
About Richard A. Heyman's insider trades
Richard A. Heyman is an insider at Oric Pharmaceuticals (ORIC). Since Apr 1, 2021, Richard has reported no open-market purchases and 38 sales worth $1.7M on SEC Form 4. In the last 12 months: 8 sales ($584K).
Their filings also include grants and awards (33 filings), option exercises (3 filings), shares returned to the company (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ORIC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.